Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 4 (2007), Issue 5 (May)

1. A case of axial undifferentiated spondyloarthritis diagnosis and management.
   Nat Clin Pract Rheumatol, 3(5): 298-303. [Abstract] [Full-text]
2. Interleukin-18 gene polymorphism, but not interleukin-2 gene polymorphism, is associated with rheumatoid arthritis.
   Immunogenetics, 59(6): 433-9. [Abstract] [Full-text]
3. The validity and reliability of PressureStat for measuring plantar foot pressures in patients with rheumatoid arthritis.
   Clin Biomech (Bristol, Avon), 22(5): 603-6. [Abstract] [Full-text]
4. Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure.
   Expert Opin Biol Ther, 7(5): 617-25. [Abstract] [Full-text]
5. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
   J Autoimmun, 28(2): 69-75. [Abstract] [Full-text]
6. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
   Clin Vaccine Immunol, 14(5): 549-55. [Abstract] [Full-text]
7. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.
   Immunol Lett, 110(1): 54-64. [Abstract] [Full-text]
8. Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02.
   Eur J Gastroenterol Hepatol, 19(6): 493-8. [Abstract] [Full-text]
9. Not all "quality-adjusted life years" are equal.
   J Clin Epidemiol, 60(6): 616-24. [Abstract] [Full-text]
10. Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis.
    Clin Exp Immunol, 148(3): 410-8. [Abstract] [Full-text]
11. Rheumatoid arthritis and reproduction.
    Rheum Dis Clin North Am, 33(2): 319-43, vi-vii. [Abstract] [Full-text]
12. No association in frequency of KIR receptors in patients with rheumatoid arthritis from Northern Ireland.
    Tissue Antigens, 69(6): 577-82. [Abstract] [Full-text]
13. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy.
    Immunol Rev, 217: 38-52. [Abstract] [Full-text]
14. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
    Arthritis Rheum, 57(4): 679-85. [Abstract] [Full-text]
15. Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls.
    Arthritis Rheum, 57(4): 672-8. [Abstract] [Full-text]
16. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
    Arthritis Rheum, 57(4): 639-47. [Abstract] [Full-text]
17. Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.
    Arthritis Rheum, 56(5): 1648-57. [Abstract] [Full-text]
18. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Arthritis Rheum, 56(5): 1497-506. [Abstract] [Full-text]
19. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Arthritis Rheum, 56(5): 1464-77. [Abstract] [Full-text]
20. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Arthritis Rheum, 56(5): 1454-63. [Abstract] [Full-text]
21. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.
    Arthritis Rheum, 56(5): 1446-53. [Abstract] [Full-text]
22. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Arthritis Rheum, 56(5): 1433-9. [Abstract] [Full-text]
23. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
    Arthritis Rheum, 56(5): 1424-32. [Abstract] [Full-text]
24. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
    Arthritis Rheum, 56(5): 1417-23. [Abstract] [Full-text]
25. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study.
    Arthritis Rheum, 56(5): 1408-16. [Abstract] [Full-text]
26. Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome.
    Proteomics, 7(10): 1634-43. [Abstract] [Full-text]
27. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.
    Pharmacogenet Genomics, 17(6): 383-90. [Abstract] [Full-text]
28. Acute-phase response, clinical measures and disease activity in ankylosing spondylitis.
    Joint Bone Spine, 74(3): 249-53. [Abstract] [Full-text]
29. Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis.
    Joint Bone Spine, 74(3): 254-8. [Abstract] [Full-text]
30. Association between rheumatoid arthritis and primary biliary cirrhosis.
    Joint Bone Spine, 74(3): 279-81. [Abstract] [Full-text]
31. Are there common human leucocyte antigen associations in juvenile idiopathic arthritis and periodontitis?
    J Clin Periodontol, 34(6): 492-8. [Abstract] [Full-text]
32. Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis.
    Atherosclerosis, 192(2): 391-5. [Abstract] [Full-text]
33. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
    Ann Rheum Dis, 66(6): 732-9. [Abstract] [Full-text]
34. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Ann Rheum Dis, 66(6): 771-7. [Abstract] [Full-text]
35. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Ann Rheum Dis, 66(6): 790-7. [Abstract] [Full-text]
36. Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
    Ann Rheum Dis, 66(6): 812-4. [Abstract] [Full-text]
37. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians.
    Ann Rheum Dis, 66(6): 803-6. [Abstract] [Full-text]
38. Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis.
    Ann Rheum Dis, 66(6): 727-31. [Abstract] [Full-text]
39. Ultrasonographic measurement of the median nerve in patients with rheumatoid arthritis without symptoms or signs of carpal tunnel syndrome.
    Ann Rheum Dis, 66(6): 825-7. [Abstract] [Full-text]
40. IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis.
    Ann Rheum Dis, 66(6): 828-31. [Abstract] [Full-text]
41. Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis.
    Ann Rheum Dis, 66(6): 818-20. [Abstract] [Full-text]
42. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.
    Ann Rheum Dis, 66(6): 712-9. [Abstract] [Full-text]
43. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
    BMC Musculoskelet Disord, 8: 37. [Abstract] [Full-text]
44. A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis.
    Curr Med Res Opin, 23(5): 961-8. [Abstract] [Full-text]
45. Cytokines in the pathogenesis of rheumatoid arthritis.
    Nat Rev Immunol, 7(6): 429-42. [Abstract] [Full-text]
46. Association of HLA genes with ankylosing spondylitis in Han population of eastern China.
    Scand J Immunol, 65(6): 559-66. [Abstract] [Full-text]
47. Histamine in rheumatoid arthritis.
    Scand J Immunol, 65(6): 530-7. [Abstract] [Full-text]
48. Asthma remission in a patient with rheumatoid arthritis while on antiangiogenesis therapy during a rheumatoid arthritis trial demonstrated by forced oscillation and spirometry.
    J Asthma, 44(4): 281-3. [Abstract] [Full-text]
49. Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population.
    J Hum Genet, 52(6): 557-60. [Abstract] [Full-text]
50. Automated segmentation and quantification of inflammatory tissue of the hand in rheumatoid arthritis patients using magnetic resonance imaging data.
    Artif Intell Med, 40(2): 65-85. [Abstract] [Full-text]
51. Primary localized cutaneous amyloidosis with unusual clinical features in a patient with Sjögren's syndrome.
    J Dermatol, 34(6): 394-6. [Abstract] [Full-text]
52. Emerging targets of biologic therapies for rheumatoid arthritis.
    Nat Clin Pract Rheumatol, 3(6): 336-45. [Abstract] [Full-text]
53. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Nat Clin Pract Rheumatol, 3(6): 328-35. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.